Abstract
DNA fragmentation is one of the critical steps in apoptosis, which is induced by DNA fragmentation factor (DFF). DFF is composed of two subunits, a 40 kDa caspase-activated nuclease (DFF40) and a 45 kDa inhibitor (DFF45). Recently a novel family of cell-death-inducing DFF45-like effectors (CIDEs) has been identified. Among CIDEs, two from human (CIDE-A and CIDE-B) and three from mouse (CIDE-A, CIDE-B and FSP27) have been reported. In this study human CIDE-3, a novel member of CIDEs, was identified upon sequence analysis of a previously unidentified cDNA that encoded a protein of 238 amino acids. It was shown to be a human homologue of mouse FSP27, and shared homology with the CIDE-N and CIDE-C domains of CIDEs. Apoptosis-inducing activity was clearly shown by DNA-fragmentation assay of the nuclear DNA of CIDE-3 transfected 293T cells. The expression pattern of CIDE-3 was different from that of CIDE-B. As shown by Northern-blot analysis, CIDE-3 was expressed mainly in human small intestine, heart, colon and stomach, while CIDE-B showed strong expression in liver and small intestine and at a lower level in colon, kidney and spleen. Green-fluorescent-protein-tagged CIDE-3 was revealed in some cytosolic corpuscles. Alternative splicing of the CIDE-3 gene was also identified by reverse transcription PCR, revealing that two transcripts, CIDE-3 and CIDE-3alpha, were present in HepG2 and A375 cells. CIDE-3 comprised a full-length open reading frame with 238 amino acids; in CIDE-3alpha exon 3 was deleted and it encoded a protein of 164 amino acids. Interestingly the CIDE-3alpha isoform still kept the apoptosis-inducing activity and showed the same pattern of subcellular localization as CIDE-3. Consistent with its chromosome localization at 3p25, a region associated with high frequency loss of heterozygosity in many tumours, CIDE-3 may play an important role in prevention of tumorigenesis.
Full Text
The Full Text of this article is available as a PDF (370.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alimov A., Kost-Alimova M., Liu J., Li C., Bergerheim U., Imreh S., Klein G., Zabarovsky E. R. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma. Oncogene. 2000 Mar 9;19(11):1392–1399. doi: 10.1038/sj.onc.1203449. [DOI] [PubMed] [Google Scholar]
- Chen Z., Guo K., Toh S. Y., Zhou Z., Li P. Mitochondria localization and dimerization are required for CIDE-B to induce apoptosis. J Biol Chem. 2000 Jul 28;275(30):22619–22622. doi: 10.1074/jbc.C000207200. [DOI] [PubMed] [Google Scholar]
- Chung T. K., Cheung T. H., Lo W. K., Yu M. Y., Hampton G. M., Wong H. K., Wong Y. F. Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intraepithelial neoplasia. Cancer Lett. 2000 Jun 30;154(2):189–194. doi: 10.1016/s0304-3835(00)00398-0. [DOI] [PubMed] [Google Scholar]
- Compton M. M. A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev. 1992 Sep;11(2):105–119. doi: 10.1007/BF00048058. [DOI] [PubMed] [Google Scholar]
- Danesch U., Hoeck W., Ringold G. M. Cloning and transcriptional regulation of a novel adipocyte-specific gene, FSP27. CAAT-enhancer-binding protein (C/EBP) and C/EBP-like proteins interact with sequences required for differentiation-dependent expression. J Biol Chem. 1992 Apr 5;267(10):7185–7193. [PubMed] [Google Scholar]
- Don R. H., Cox P. T., Wainwright B. J., Baker K., Mattick J. S. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 1991 Jul 25;19(14):4008–4008. doi: 10.1093/nar/19.14.4008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998 Jan 1;391(6662):43–50. doi: 10.1038/34112. [DOI] [PubMed] [Google Scholar]
- Fullwood P., Marchini S., Rader J. S., Martinez A., Macartney D., Broggini M., Morelli C., Barbanti-Brodano G., Maher E. R., Latif F. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Cancer Res. 1999 Sep 15;59(18):4662–4667. [PubMed] [Google Scholar]
- Hirano A., Emi M., Tsuneizumi M., Utada Y., Yoshimoto M., Kasumi F., Akiyama F., Sakamoto G., Haga S., Kajiwara T. Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer. Clin Cancer Res. 2001 Apr;7(4):876–882. [PubMed] [Google Scholar]
- Inohara N., Koseki T., Chen S., Wu X., Núez G. CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor. EMBO J. 1998 May 1;17(9):2526–2533. doi: 10.1093/emboj/17.9.2526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Inohara N., Nuñez G. Genes with homology to DFF/CIDEs found in Drosophila melanogaster. Cell Death Differ. 1999 Sep;6(9):823–824. doi: 10.1038/sj.cdd.4400570. [DOI] [PubMed] [Google Scholar]
- Kayahara H., Yamagata H., Tanioka H., Miki T., Hamakawa H. Frequent loss of heterozygosity at 3p25-p26 is associated with invasive oral squamous cell carcinoma. J Hum Genet. 2001;46(6):335–341. doi: 10.1007/s100380170069. [DOI] [PubMed] [Google Scholar]
- Kozak M. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987 Oct 26;15(20):8125–8148. doi: 10.1093/nar/15.20.8125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 1997 Apr 18;89(2):175–184. doi: 10.1016/s0092-8674(00)80197-x. [DOI] [PubMed] [Google Scholar]
- Louhelainen J., Wijkström H., Hemminki K. Multiple regions with allelic loss at chromosome 3 in superficial multifocal bladder tumors. Int J Oncol. 2001 Jan;18(1):203–210. doi: 10.3892/ijo.18.1.203. [DOI] [PubMed] [Google Scholar]
- Luft F., Gebert J., Schneider A., Melsheimer P., von Knebel Doeberitz M. Frequent allelic imbalance of tumor suppressor gene loci in cervical dysplasia. Int J Gynecol Pathol. 1999 Oct;18(4):374–380. doi: 10.1097/00004347-199910000-00013. [DOI] [PubMed] [Google Scholar]
- Lugovskoy A. A., Zhou P., Chou J. J., McCarty J. S., Li P., Wagner G. Solution structure of the CIDE-N domain of CIDE-B and a model for CIDE-N/CIDE-N interactions in the DNA fragmentation pathway of apoptosis. Cell. 1999 Dec 23;99(7):747–755. doi: 10.1016/s0092-8674(00)81672-4. [DOI] [PubMed] [Google Scholar]
- Maestro M. L., del Barco V., Sanz-Casla M. T., Moreno J., Adrover E., Izquierdo L., Zanna I., Fernández C., Redondo E., Blanco J. Loss of heterozygosity on the short arm of chromosome 3 in renal cancer. Oncology. 2000 Aug;59(2):126–130. doi: 10.1159/000012149. [DOI] [PubMed] [Google Scholar]
- Maitra A., Wistuba I. I., Washington C., Virmani A. K., Ashfaq R., Milchgrub S., Gazdar A. F., Minna J. D. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol. 2001 Jul;159(1):119–130. doi: 10.1016/S0002-9440(10)61679-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nagata S. Apoptosis by death factor. Cell. 1997 Feb 7;88(3):355–365. doi: 10.1016/s0092-8674(00)81874-7. [DOI] [PubMed] [Google Scholar]
- Phillips J. L., Ghadimi B. M., Wangsa D., Padilla-Nash H., Worrell R., Hewitt S., Walther M., Linehan W. M., Klausner R. D., Ried T. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease. Genes Chromosomes Cancer. 2001 May;31(1):1–9. doi: 10.1002/gcc.1111. [DOI] [PubMed] [Google Scholar]
- Rigaud G., Moore P. S., Zamboni G., Orlandini S., Taruscio D., Paradisi S., Lemoine N. R., Klöppel G., Scarpa A. Allelotype of pancreatic acinar cell carcinoma. Int J Cancer. 2000 Dec 1;88(5):772–777. doi: 10.1002/1097-0215(20001201)88:5<772::aid-ijc14>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
- Shapiro M. B., Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 1987 Sep 11;15(17):7155–7174. doi: 10.1093/nar/15.17.7155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 1995 Mar 10;267(5203):1456–1462. doi: 10.1126/science.7878464. [DOI] [PubMed] [Google Scholar]
- Vaux D. L., Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2239–2244. doi: 10.1073/pnas.93.6.2239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Webb S. J., Harrison D. J., Wyllie A. H. Apoptosis: an overview of the process and its relevance in disease. Adv Pharmacol. 1997;41:1–34. doi: 10.1016/s1054-3589(08)61052-2. [DOI] [PubMed] [Google Scholar]
- Wyllie A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980 Apr 10;284(5756):555–556. doi: 10.1038/284555a0. [DOI] [PubMed] [Google Scholar]
- Wyllie A. H., Kerr J. F., Currie A. R. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]
- Wyllie A. H., Morris R. G., Smith A. L., Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol. 1984 Jan;142(1):67–77. doi: 10.1002/path.1711420112. [DOI] [PubMed] [Google Scholar]
- Xu Y., Uberbacher E. C. Automated gene identification in large-scale genomic sequences. J Comput Biol. 1997 Fall;4(3):325–338. doi: 10.1089/cmb.1997.4.325. [DOI] [PubMed] [Google Scholar]